Spastic Gait
Watchlist
Retrieved
2021-01-18
Source
Trials
—
Genes
L1CAM,
MSL3,
SOD1,
TTC19,
ABCD1,
WDR48,
GJC2,
ATAD3A,
MSTO1,
ZFR,
GBA2,
REEP2,
ATL1,
BSCL2,
DSTYK,
ZFYVE26,
ALS2,
REEP1,
SPART,
UBA5,
L2HGDH,
PGAP1,
SPG11,
WDR26,
DDHD1,
C19orf12,
MFSD2A,
CYP2U1,
ZFYVE27,
NIPA1
L1CAM,
MSL3,
SOD1,
TTC19,
ABCD1,
WDR48,
GJC2,
ATAD3A,
MSTO1,
ZFR,
GBA2,
REEP2,
ATL1,
BSCL2,
DSTYK,
ZFYVE26,
ALS2,
REEP1,
SPART,
UBA5,
L2HGDH,
PGAP1,
SPG11,
WDR26,
DDHD1,
C19orf12,
MFSD2A,
CYP2U1,
ZFYVE27,
NIPA1,
CPT1C,
DDHD2,
CCT5,
NT5C2,
SPG7,
KIF1A,
CSF1R,
B4GALNT1,
HSPD1,
KCNA1,
KCNA4,
KIF5A,
MECP2,
PLP1,
ALDH18A1,
RTN2,
SPAST,
VAMP1,
APC,
VCP,
CACNA1G,
USP8,
SLC33A1,
CYP7B1,
KMT2B,
TECPR2,
WASHC5,
AP5Z1,
SLC25A15,
ERLIN1,
ERLIN2,
ARSI
Drugs
—
Registered!
Spastic gait is a form of gait abnormality.
Among the treatment options is chemodenervation.
Presentation
Asymmetric foot dragging.
Conditions associated with a spastic gait
- Brain tumor
- Brain abscess
- Sturge-Weber syndrome
- Cerebral palsy
- Cerebrovascular accident
- Multiple sclerosis